Filter
423
Filtered Results: 423
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
59
New Publications
132
Language
Document type
No document type
222
Guidelines
79
Studies & Reports
53
Strategic & Response Plan
26
Manuals
22
Fact sheets
8
Training Material
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Videos
1
Countries / Regions
Kenya
26
South Africa
16
India
16
Ghana
15
Nigeria
15
Western and Central Europe
14
Uganda
14
Eastern Europe
11
Ethiopia
11
Nepal
10
Rwanda
10
Namibia
10
Global
9
Sierra Leone
8
Malawi
8
Tanzania
8
Zambia
8
Latin America and the Carribbean
6
South–East Asia Region
6
Senegal
5
Philippines
5
Cambodia
5
Bangladesh
5
Botswana
5
Liberia
5
Africa
4
West and Central Africa
4
East and Southern Africa
4
Russia
4
Lesotho
3
Zimbabwe
3
Mozambique
3
Middle East and North Africa
3
Haiti
2
Asia
2
Congo, Democratic Republic of
2
Eastern Europe and Central Asia
2
Lebanon
2
Brazil
2
Sudan
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Ukraine
1
Benin
1
Gambia
1
Cameroon
1
Syria
1
Laos
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Jordan
1
Western Pacific Region
1
Paraguay
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
217
Clinical Guidelines
55
Public Health
16
Women & Child Health
8
Pharmacy & Technologies
8
Capacity Building
6
Key Resources
6
Toolboxes
TB
51
Pharmacy
47
AMR
41
COVID-19
29
HIV
22
NTDs
20
Planetary Health
4
NCDs
4
Rapid Response
3
Caregiver
3
Refugee
2
Specific Hazards
1
Cholera
1
Ebola & Marburg
1
Malaria
1
Zika
1
Polio
1
Global Health Education
1
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
This FY 2017 Malaria Operational Plan presents a detailed implementation plan for Senegal, based on the strategies of PMI and the National Malaria Control Program (NMCP) strategy. It was developed in consultation with the NMCP and with the participation of national and international partners involve...
n 2015, Member States of the United Nations adopted the 2030 Agenda for Sustainable Development and its accompanying Sustainable Development Goals (SDGs), with the third goal of the agenda focusing on health – good health and well-being. This has the attainment of universal health coverage (UHC) a...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and vaccine procurement. Access to safe a...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
